[go: up one dir, main page]

MXPA97001795A - Coloring copuard for anali spectrophotometric determination - Google Patents

Coloring copuard for anali spectrophotometric determination

Info

Publication number
MXPA97001795A
MXPA97001795A MXPA/A/1997/001795A MX9701795A MXPA97001795A MX PA97001795 A MXPA97001795 A MX PA97001795A MX 9701795 A MX9701795 A MX 9701795A MX PA97001795 A MXPA97001795 A MX PA97001795A
Authority
MX
Mexico
Prior art keywords
test device
further characterized
enzymes
alkyl
oxidase
Prior art date
Application number
MXPA/A/1997/001795A
Other languages
Spanish (es)
Other versions
MX9701795A (en
Inventor
Siu Yu Yeung
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/302,575 external-priority patent/US5563031A/en
Application filed by Lifescan Inc filed Critical Lifescan Inc
Publication of MXPA97001795A publication Critical patent/MXPA97001795A/en
Publication of MX9701795A publication Critical patent/MX9701795A/en

Links

Abstract

The present invention relates to a coupled dye compound for use in a test de that contains a reagent system for detecting the presence of an amount of an analyte in a sample. The reagent system comprises one or more enzymes which, in the presence of the analyte, produce an oxidizing agent in amounts indicative of the amount of analyte in the sample, the compound of choice being meta-methyl-2-benzothiazolinone-hydrozone] N-sulfonylbenzenesulfonate -monosod

Description

COLORONTE COPUlDOR Pft Q SPECTRROFOTOflETRICAL DETERMINATION PE ñNLITQS CflflPQ TÉCNICO The present invention relates to a device and a test method for the color determination of chemical compounds and chemistries (analytes) in aqueous fluids, such as whole blood and, more particularly, to a pair of colorants for use on said device. and everything.
Lñ TECHNICAL PE BACKGROUND The quantification of chemical and biochemical components in colored aqueous fluids, in particular colored biological fluids, such as whole blood and urine and in biological fluid derivatives, such as serum and plasma, are of increasing importance. There are important applications in medical diagnosis and treatment and in the quantification of exposure to therapeutic drugs, intoxicants, dangerous chemical substances and the like. In some cases, the quantities of ina + enals to be determined are + an lowercase (on a scale of 1 μg or less per deciliter) or so difficult to determine with precision that the apparatus used is complicated and only useful. for expert laboratory personnel. In that case, the results are usually not available for a few hours or days after the sample is taken. In other cases, there is often an emphasis on the ability of lay operators to routinely perform the test quickly and reproducibly outside a laboratory facility, with rapid and immediate display of information. A common medical test is the measurement of blood glucose levels by diabetics. Current teaching advises diabetic patients to measure their blood glucose level two to seven times a day, depending on the nature and severity of their individual cases. Based on the pattern observed in the measured glucose levels, the patient and the doctor together make adjustments in diet, exercise and ingestion of insulin for the best management of the disease. Clearly this information must be available immediately to the patient. Many blood glucose test methods and test items have been known in the art; They all suffer from a variety of limitations. A great improvement is described and claimed in U.S. Patent Nos. 4,935,345; 5,049,487; 5,059,394 and 5,179,005 of R. Phillips and co-inventors, and that the same successor as the present application was assigned. The method described and claimed in these patents involves reading a reflective reader from an inert porous matrix impregnated with a reagent that will interact with the analyte to produce a light absorbing reaction product, when the fluid being analyzed is applied to the analyte. another surface and rotate through the matrix through the surface that is being read. The reagent includes glucose oxidase, an enzyme that consumes glucose in the sample to produce hydrogen peroxide which, in the presence of another enzyme, horseradish peroxidase, oxidizes a dye pair comprising 3-rnet? L-2-benzot hydrochloride azolmone hydrazone (M1T?) and acid 3-d? met? larn? nobenzo? co (DMPIB) to produce a blue tint. The refle measurement is carried out at two separate wavelengths. The concentration of glucose in the blood is determined based on the intensity of the color of the dye, with the help of a LED spectrototrórnet ro. In the co-pending U.S. patent application, serial number 245,940, filed May 19, 1994 (LF 30), a dye pair comprising 3-met? 1-2-benzoth-azolene hydrazone in free form or in the form of acid (MBTH) and 1-naphthalenesulphonate 1-an? Lmo in the form of acid or in salt form (RN5) to be used in place of the coloring BTH-DMAB, such as described above. The MBTH-RNS dye pair is less soluble by oxidation and, therefore, provides a stable end point with minimal colorant dimming, in comparison with the oxidized MBTH-DriRB colorant. While these prior systems have actually been employed to produce test devices useful for determining the presence or amount of glucose, several drawbacks have been noted. Test devices in which several pairs are employed are designed for both domestic and institutional use and are thus sold by manufacturers and distributors in the hope that they remain in the user's inventory for a substantial period of time. time and, of course, must remain effective during that period of time. This need for a substantial shelf life has caused difficulties in formulating products that employ MBTH as one of the components of a dye pair. First, it has been found that MBTH stability decreases with increasing temperature and alkalinity. The free acid form of MBTH is very susceptible and tends to sublimate. In an attempt to account for this, a preterm form is ol acid hydrate of MBTH, for example, the hydrochloride of 3-rnet? ] -2-benzot? Azol? Nona hydrazone. Unfortunately this hydrate itself is unstable as the temperature increases and it dissociates easily to the free acid MBTH and HC1 when heated. In addition to having low stability at a high pH, the efficiency of MBTH to react oxidant with its counterpart of the pair, greatly decreases with increasing alkalinity, so that at a high pH there is essentially little or no color from the pair Colorant.
In view of these relationships, in practice, the MBTH should be used in large excesses and at a low pH to minimize the effects of instability and inadequacy. Ideally, a pH of less than 2.0 would be preferred from the point of view of the sublimation ba a and the high efficiency of the compound. Unfortunately, for the systems that are being considered in the present, said ideal low pH can not be employed. As described above, the reactive systems used depend on enzymes that act on the substrate analyte and generate oxidation agents in amounts indicative of the amounts of the analyte present in the sample being tested. The low pH, which would be ideal with respect to the MBTH reagent, is totally inadequate for such enzymes as, for example, glucose oxidase and horseradish peroxidase, said low pH, many of the commercially available enzymes have little or no activity. Consequently, the technique has been forced to consider and select a moderate pH, for example 4 and a large excess of reagents to guarantee the efficiency of its test devices, for the required storage life.
BRFVF DESCRIPTION OF THE INVENTION In accordance with the teachings of this invention, a highly stable component of a color-ante pair is provided in a test device containing enzymes. The component, in contrast to those employed in the above test devices, is capable of oxidatively coupling efficiently with a wide variety of coupling counterparts at relatively high pH conditions compatible with the high efficiency of the enzymes. Specifically, the dye couple compound of this invention is to be used in a test device that contains a reactive system for detecting the presence or amount of an analyte in a sample, wherein the reactive system comprises one or more enzymes that, in the presence of the analyte, they produce an oxidizing agent in amounts indicative of the amount of the analyte present in the sample. In accordance with the teachings herein, the reactive system further comprises a dye pair capable of forming a chromium forum when oxidized by the oxidizing agent produced; and the dye pair comprises the compound: wherein R is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heterocyclic, quaternary amine or organic acid portions; and Y is selected from the group consisting of NOs, S03-, H, halide, alkyl or 5? Za, wherein Z is alkyl or aryl. Preferably, Y is H. In a preferred embodiment, R is: wherein any of R, Rs "and Ra is independently selected from the group consisting of H, alkyl, aplo, silyl, halide, hydroxide, ercaptide, alkoxide, thioalkoxide, amine, sulfonate or carboxylate; and X is selected from the group consisting of amine, sulfonate or carboxylate. In a specific embodiment, the test device is provided to determine the presence or amount of analytes such as glucose, cholesterol, alcohol, unco acid, formaldehyde or glycerol 3-phosphate, all blood analytes, commonly measured. In such cases, the enzyme system comprises enzymes selected from the group consisting of glucose oxidase, cholesterol oxidase, alcohol oxidase, upcase, aldehyde oxidase and glycerophosphate oxidase; together with peroxidase or an inorganic complex that has peroxidase-like activity, for example, atma, hernin and tetrakis-csulf- "ofeml3-orf? r? na-rnanganeso." A selection peroxidase is horseradish peroxidase.
BREVF DESCRIPTION OF THE DRAWINGS Figure 1 is a perspective view of an embodiment of a test device containing a reaction pad to which the liquid sample being analyzed is applied; and Figure 2 is a perspective view of a second embodiment of the test device of Figure 1.
DISCUSSION PETRLLRPñ PE Lñ INVENCIÓN As described above, the invention involves an improved dye compound for use in a test device for determining the presence or amount of an analyte in a liquid sample. With reference to Figure 1, in a preferred embodiment of this invention, the test device comprises a porous matrix 10 having a chemical reagent system incorporated therein and which is adhered to a support 12. It is provided with an opening 16 through the support, by which a liquid sample can be applied to a sample receiving surface 17 of the matrix 10. The chemical system is provided to react with any analyte present in the liquid sample and as a result of which a surface of test 19 of the matrix with a manifest luminous reflection, indicating the amount of analyte present in the liquid sample. The test surface can be read at a glance, but is preferably read by using a photometpco spectrum matrix device. The elements of said devices are shown schematically in FIG. 1 and comprise a light source 18, such as a light emitting diode for preferably directing a light of uniform wavelength on the test surface 19. The light detector 20 for detecting light reflected from surface 19 and producing a signal 22 indicating the amount of light detected, which signal can be processed, for example, by a microprocessor incorporated in the reading device? ar-to calculate the amount of analyte present in the sample. Systems such as that described above are known in the art and are well described in U.S. Patent Nos. 4,935,345; 5,049,487; 5,059,394 and 5,179,005. Said systems contemplate that these test devices will be inserted into the reader section and then a sample, for example blood, will be applied to the sample receiving surface 17. Figure 2 represents an alternative to this, where the blood is first applied to the sample receiving surface 7 and only then is the test surface 19 presented to the display for reading. In all other senses, the elements numbered in Figure 2 are identical to those in Figure 1. The reflective properties of the test surface vary with the amount of analyte present in the sample by the operation of a series of reactions. between the analyte present in the liquid sample and the chemical reagents present in the porous matrix. In particular, the matrix includes one or more enzymes which, together with the analyte substitute, result in the production of hydrogen peroxide or other strong oxidizing agents. A colorant is included in the matrix, ie, two compounds that are capable of being oxidized to form a chromophore that absorbs light at a specific wavelength, in proportion to the amount of chromophore present. The oxidizing agent formed by the enzyme-catalyzed reaction then reacts with the dye sample to produce the chromophore. The selection of the enzymes, the resulting oxidizing agent and the selection of the coloring pair vary widely in the art and, to a large extent, are a function of the analyte that is being determined. For example, in the case of the determination of cholesterol as in a blood sample, an enzyme oxidase, such as cholesterol oxidase can be employed. Similarly, alcohol oxidase can be used in the determination of methanol or ethanol; formaldehyde determinations may employ aldehyde-oxi dasa; or glycerol 3-phosphate determinations may employ glycerophosphate oxidase. The hydrogen peroxide product of these enzyme-catalyzed reactions can be further modified by a subsequent reaction catalyzed by an enzyme to produce a reactive oxidizing agent to react with the dye pair to form the chronophore. physiological, for example, the reaction of hydrogen peroxide to form an active oxidant reagent can be catalyzed by the horseradish peroxidase enzyme. Accordingly, while it will be understood that the teachings of this invention are broadly applicable, for the purpose of the discussion that follows, the analyte will be exemplified by glucose in a liquid sample of whole blood. The preferred chemical system will then be exemplified by the enzyme glucose oxidase which acts on the glucose substrate to form hydrogen peroxide. The hydrogen peroxide, in turn, is converted to the active oxidant reagent by reaction with another enzyme, horseradish peroxidase. Heretofore, the dye pair widely used in a glucose test of the type described above, was the combination of 3 ™ rnethyl-2-benzothiazolinone hydrazone hydrochloride hydrate (MBTH hydrochloride hydrate) (formula I), together with dirnetyl-n-benzene (formula II). These compounds undergo the following oxidation reaction to form a blue chromophore (formula III): CO] = hydrogen peroxide / horseradish peroxidase As described above, this system suffers from several disadvantages. MBTH, even in the form of hydrochloride hydrate, is relatively unstable under the action of heat and alkalinity. Additionally, the above reaction is very inefficient under strongly acidic conditions, for example, pH 2 or less. Unfortunately, at those conditions the enzymes employed in the test devices, for example, glucose oxidase and horseradish peroxidase, have little or no activity. Accordingly, commercial practice has dictated that, in order to obtain a relatively stable system, an optimum pH be used, for example, about 4, and large amounts of enzymes and the coloring pair are used to constitute the decreased activity of the enzymes. and the reduced efficiency of the oxidation of the coupling reaction. In accordance with this invention, it has now been discovered that modified forms of MBTH can be provided that solve the stability problem hitherto encountered and are also efficiently reactive in an environment that further leads to the activity of the enzymes employed in the test employed here as, for example, at pH values ranging from 4 to 7, approximately. Some preferred derivatives, moreover, have been found to be highly reactive for the suitable coupling partners, the aromatic amines. The derivatives of the invention have the general structure indicated in formula IV that follows: wherein R is selected from the group consisting of the alkyl, substituted alkyl, aplo, substituted aryl, heterocyclic, quaternary amine or organic acid moieties; and Y is selected from the group consisting of NOs ", S03-, H, halide, alkyl or S? Za, wherein Z is alkyl or ryl. Preferably Y is H. In a preferred embodiment R is: wherein any of R, 2 and Ra is independently selected from the group consisting of H, alkyl, aryl, silyl, halide, hydroxide, cyclopentadide, alkoxide, thioalkoxide, amine, sulfonate or carboxylate; and X is selected from the group consisting of amine, sulfonate or carboxylate. The MBTH derivatives of this invention can be subjected to an oxidation reaction with a broad scale of dye pair partners, such as aromatic amines, phenols and substituted phenols. In addition, said reactions can proceed efficiently at room temperature, at pH values that can vary from 4 to 11. In the preferred form of the derivatives of this invention, the oxidation reaction is optimal at approximate pH values. from 4 to 7 and, therefore, is particularly useful in conjunction with the amine dye couple partners of interest in diagnostic chemistry, such as 3-d-r-ilanoinobenzoic acid and 1-naphthalensulphonates of 8-an ? l? no. In contrast to MBTH, either in the form of free acid or in the form of the acid hydrate, these derivatives are remarkably stable even when heated at 10 ° C for up to 1 (5 hours. oxidation, enzymes that catalyze peroxide, such as horseradish peroxide, are especially effective to carry out the coupling reaction by oxidation.
E3E11PLQ 1 SYNTHESIS BEL PERIVRPO PE? BTH SYNTHESIS OF N-SULFONILBENCENSU FONRTO MONOSODIC C21 OF METAC3-METHYL-2-ENZOTITIZED INONfl HI RPZON 1 REACTION SCHEME Material 3-Rhenethyl-2-benzothiazolinone hydrochloride (MBTH-HC1), Nal, hydroxide and tetrabutylammonium, methylene chloride and n-methyl-2-? -rolidolone were purchased from Rldrich Company of Milwau ee, Wisconsin, and are used without purification. Tpeti lamina is obtained from Baker Chemicals and distributed by Baxter-Company of Phillipsburg, New Jersey. Benzene 1,3-disulfonylchloride was purchased from Fluka Chemical, from Ronkonkona, New York or Lancaster Chemical from Umdharn, New Hanpshire.
Synthesis of (1) A sample of 4 g of MBTH-HC1 was loaded into an Erlen eyer 150-ml flask., equipped with magnetic stirring bar, and added 50 rnl of l-rnet? i ~? -p? rrol? dona and 5 ml of triethylanine. The flask was covered with a rubber septum and placed on a hot plate with magnetic stirring. The mixture was heated at 60-70 ° C while stirring vigorously for 0.5 hours, which produced a yellow suspension. The flask was placed in an ice bath to cool. A 5 g sample of 1,3-d-sulphonyl benzene fomlchloride was added to a 250 ml Erlenmeyer flask equipped with a magnetic stir bar. The flask was lowered onto an ice bath and 20 ml of n-met l-2-pyrrolidone was added. The mixture was stirred until all the solids had dissolved (approximately 15 minutes). The free base suspension of MBTH, which was previously obtained, was decanted over the solution. The resulting light yellow mixture was reacted at an ice bath temperature for 1.5 hours. After that time the reaction was quenched with 10 ml of 2 N HCl and stirred for another 30 minutes at room temperature. 50 ng of Nortí (activated carbon pellets) of 12 meshes were introduced into the solution, which produced a light yellow solution after 10 minutes of stirring. It was filtered through a fine grade fry with the help of a vacuum cleaner. A uniform yellow to light brown solution was obtained. 300 ml of 2 N HCl was added to the yellow solution which was stirred, resulting in the precipitation of a white matte powder. The solid was collected by vacuum filtration and the solid was washed three times with 25 ml of deionized water. Upon drying at 110 ° C under vacuum for 2 hours, 5.6 g of the white matte product was obtained. The product was analyzed with NMR with H and HPLC, yielding a purity of 97%. The compound (1) is not very soluble in most common organic solvents or in water. However, it is soluble in the basic solution and in polar solvents, such as DMSO, NMP and DMF.
Synthesis of (2) 2.0 g of crude oil sample (1) was suspended in 50 ml of methylene chloride. 4 ml of 1 M tetrabutyranonium hydroxide was slowly added over the course of 2 minutes to the suspension under stirring; which produced a light yellow solution. The solution was washed with 10 ml of deionized water and dried over anhydrous sodium sulfate. The sulfate was removed by gravity filtration and the resulting mixture was evaporated to dryness in a rotary evaporator. The thick yellow oil was collected. The oil was collected with 13 125 ml of acetone and 10 ml of 20% Nal in acetone was added over the course of 5 minutes. A white precipitate was evident. The mixture was allowed to react for another 20 minutes and the precipitate was collected by vacuum filtration with a fine grade fritter. The resulting white-matt solid was washed three times with 20 ml of acetone. On drying at 110 ° C for 45 minutes 1.3 g (65%) of the desired product was obtained. The compound (2) is very soluble in water and in a water-alcohol mixture. The solid is stable in air and light, but its solution slowly decomposes to a turbid, light yellow mixture when exposed to light for extended periods of time.
EXAMPLE 2 PREPRENCIATION PE A PISPQSITIVQ PE PROOF A strip of polymer membrane (reaction matrix) is immersed in an aqueous immersion of table 1 until it becomes saturated. It is removed from the immersion and the excess reagent is squeezed with a glass rod. The strip is then hung inside a circulating air oven at 56 ° C for 5 to 10 minutes to dry, and after that time the strip is removed and immersed in the organic immersion described in table .1 until It is saturated. Again dry as in the previous step. The resulting strip is shaped as desired, to perform the test, OUADRO i FORMULATION OF REAGENTS Aqueous immersion Organic immersion (adjust pH to 4.25 with NaOH) Rgua 20 mi Rgua 3 mi Citric acid 420 my Ethyl diamine monoalonate alcohol 16.7 mg N-sulfonylbenzene 10-tetraacetic acid (EDTR) monosodium monohydrogen (2) meta-L "3-rnethyl-2-benzothiazolinone hydrazone] Gantrez S 5 90 rng flNS 10 - (obtainable from GRF, 100 mg New York, New York) Crotein SPA 250 ng (obtainable from Croda Co. New York, New York) Glucose-oxid sa 20,500 units Horseradish peroxidase 16,200 spicy units EXAMPLE 3 ETERMINATION PE 6LUCQSR A blood sample containing glucose is applied to the surface of the strip impregnated with the reagents.
The sample inside the matrix is immediately absorbed and a blue color is apparent. The intensity of color increases with time and is proportional to the concentration of the analyte. Based on the color intensity, the glucose concentration is determined by comparing with a standard calibration curve. Similarly, an aqueous solution of hydrogen peroxide (organic peroxides, ferric and quinone) also produces the desired blue color in the strip impregnated with reagent. The concentration of the analyte can be determined by the same means as above. The invention having been fully described, it will be evident to the person skilled in the art that any modification and change can be made therein without departing from the spirit and scope of the invention.

Claims (9)

NQVEPRP PE LR INVENTION CLAIMS
1. - In a test device containing a reactive system for determining the presence or quantity of an analyte in a sample, wherein the reactive system comprises enzymes to produce an oxidizing agent in amounts that indicate the amounts of the analyte present in the sample; the improvement characterized in that: the r-active system comprises a dye pair that forms a chromophore when oxidized by said oxidizing agent; the dye pair comprising a compound having the formula: wherein R is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heterocyclic, quaternary amine or organic acid portions; and Y is selected from the group consisting of NOa, SOa-, H, halogenide, alkyl or S? Za, wherein Z is alkyl or an ilo.
2. The test device according to claim 1, further characterized in that R is: wherein any of R, R "and Ra are independently selected from the group consisting of H, alkyl, aryl, silyl, halide, hydroxide, mercaptide, alkoxide, thioalkoxide, amine, sulfonate or carboxylate; and X is selected from the group consisting of amine, sulfonate or carboxylate.
3. The test device according to claim 2, further characterized in that Y is H.
4. The test device according to claim 1, further characterized in that the enzymes are selected from the group consisting of glucose oxidase. , cholesterol oxidase, alcohol -oxidase, uricase, aldehyde oxidase and glycerophosphate -oxidase.
5. The test device according to claim 4, further characterized in that the enzymes additionally comprise peroxidase or an inorganic complex having properties similar to peroxidase.
6. The test device according to claim 4, further characterized in that the enzymes comprise gl? Seoxidase and horseradish peroxidase.
7. The test device according to claim 1, further characterized in that the dye pair further comprises 3-dirnethylaminobenzoic acid.
8. The test device according to claim 1, further characterized in that the dye pair additionally comprises 8-anilino l-naphthalene sulfonate.
9. The test device according to claim 1, further characterized in that the compound is monosodium N-sulfonylbenzenesulfonate of metaC3-methyl-2-benzothiazolinone hydrazone.
MX9701795A 1994-09-08 1995-09-07 Highly stable oxidative coupling dye for spectrophotometric determination of analytes. MX9701795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/302,575 US5563031A (en) 1994-09-08 1994-09-08 Highly stable oxidative coupling dye for spectrophotometric determination of analytes
US08302575 1994-09-08
PCT/US1995/012091 WO1996007757A1 (en) 1994-09-08 1995-09-07 Dye couple for spectrophotometric determination of analytes

Publications (2)

Publication Number Publication Date
MXPA97001795A true MXPA97001795A (en) 1997-06-01
MX9701795A MX9701795A (en) 1997-06-28

Family

ID=23168337

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701795A MX9701795A (en) 1994-09-08 1995-09-07 Highly stable oxidative coupling dye for spectrophotometric determination of analytes.

Country Status (15)

Country Link
US (1) US5563031A (en)
EP (2) EP1167540B1 (en)
JP (1) JP3755828B2 (en)
KR (1) KR100402876B1 (en)
CN (1) CN100357449C (en)
AT (2) ATE365226T1 (en)
AU (1) AU688138B2 (en)
CA (1) CA2199490C (en)
DE (2) DE69535522T2 (en)
DK (2) DK0781350T3 (en)
ES (2) ES2179885T3 (en)
MX (1) MX9701795A (en)
NO (1) NO318023B1 (en)
PT (2) PT781350E (en)
WO (1) WO1996007757A1 (en)

Families Citing this family (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935346A (en) 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5922530A (en) * 1994-09-08 1999-07-13 Lifescan, Inc. Stable coupling dye for photometric determination of analytes
AU722471B2 (en) 1995-10-17 2000-08-03 Lifescan, Inc. Blood glucose strip having reduced sensitivity to hematocrit
US5776719A (en) * 1997-07-07 1998-07-07 Mercury Diagnostics, Inc. Diagnostic compositions and devices utilizing same
US5989845A (en) * 1996-04-05 1999-11-23 Mercury Diagnostics, Inc. Diagnostic compositions and devices utilizing same
US6040151A (en) 1998-03-10 2000-03-21 Mercury Diagnostics, Inc. Diagnostic compositions and devices utilizing same
US5962215A (en) 1996-04-05 1999-10-05 Mercury Diagnostics, Inc. Methods for testing the concentration of an analyte in a body fluid
EP1579814A3 (en) 1996-05-17 2006-06-14 Roche Diagnostics Operations, Inc. Methods and apparatus for sampling and analyzing body fluid
US20020010406A1 (en) 1996-05-17 2002-01-24 Douglas Joel S. Methods and apparatus for expressing body fluid from an incision
US5846486A (en) * 1996-08-09 1998-12-08 Lifescan, Inc. Hollow frustum reagent test device
US5753429A (en) * 1996-08-09 1998-05-19 Lifescan, Inc. Analyte concentration measurement using a hollow frustum
US5736103A (en) 1996-08-09 1998-04-07 Lifescan, Inc. Remote-dosing analyte concentration meter
US6099802A (en) * 1996-08-09 2000-08-08 Lifescan, Inc. Hollow frustum reagent test device
GB2332943B (en) * 1996-10-30 2000-01-19 Mercury Diagnostics Inc Detection device
US5948695A (en) * 1997-06-17 1999-09-07 Mercury Diagnostics, Inc. Device for determination of an analyte in a body fluid
US6168957B1 (en) * 1997-06-25 2001-01-02 Lifescan, Inc. Diagnostic test strip having on-strip calibration
US7390667B2 (en) 1997-12-22 2008-06-24 Roche Diagnostics Operations, Inc. System and method for analyte measurement using AC phase angle measurements
US7407811B2 (en) 1997-12-22 2008-08-05 Roche Diagnostics Operations, Inc. System and method for analyte measurement using AC excitation
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US7494816B2 (en) 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6111639A (en) * 1998-05-06 2000-08-29 Reduto; Lawrence A. Method and apparatus for countering adverse drug events
US6124242A (en) * 1998-06-26 2000-09-26 Basf Aktiengesellschaft Herbicidal compositions and processes based on ferrodoxin:NADP reductase inhibitors
US6162397A (en) * 1998-08-13 2000-12-19 Lifescan, Inc. Visual blood glucose test strip
WO2000012173A1 (en) 1998-08-31 2000-03-09 Johnson & Johnson Consumer Companies, Inc. Electrotransport device comprising blades
US7700305B2 (en) 1999-09-17 2010-04-20 N2Itive1 Innovations Analyte detection
US6656697B1 (en) * 1998-09-28 2003-12-02 Lifescan, Inc. Diagnostics based on tetrazolium compounds
US8419650B2 (en) 1999-04-16 2013-04-16 Cariocom, LLC Downloadable datasets for a patient monitoring system
US6678554B1 (en) 1999-04-16 2004-01-13 Johnson & Johnson Consumer Companies, Inc. Electrotransport delivery system comprising internal sensors
US6290646B1 (en) 1999-04-16 2001-09-18 Cardiocom Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients
US6762158B2 (en) 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US7074747B1 (en) 1999-07-01 2006-07-11 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
AU5764800A (en) 1999-07-01 2001-01-22 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
US20050009717A1 (en) * 1999-07-01 2005-01-13 Lukenbach Elvin R. Foaming make-up removing cleansing compositions
US6218571B1 (en) * 1999-10-27 2001-04-17 Lifescan, Inc. 8-(anilino)-1-naphthalenesulfonate analogs
US6458326B1 (en) 1999-11-24 2002-10-01 Home Diagnostics, Inc. Protective test strip platform
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6635439B2 (en) 2000-12-21 2003-10-21 Ethicon, Inc. Hydrogen peroxide indicator employing enzyme and dye
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
WO2002100251A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
WO2002100460A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Electric lancet actuator
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
EP1404235A4 (en) 2001-06-12 2008-08-20 Pelikan Technologies Inc METHOD AND APPARATUS FOR INTEGRATED LANCET LAUNCH DEVICE ON BLOOD SAMPLING CARTRIDGE
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US6844149B2 (en) 2001-06-29 2005-01-18 International Business Machines Corporation Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements
US6749887B1 (en) 2001-11-28 2004-06-15 Lifescan, Inc. Solution drying system
US6872358B2 (en) 2002-01-16 2005-03-29 Lifescan, Inc. Test strip dispenser
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
TW568772B (en) * 2002-12-31 2004-01-01 Veutron Corp Apparatus with a combination of a point light source and a single lens
US6900058B2 (en) * 2003-03-11 2005-05-31 Bionostics, Inc. Control solution for photometric analysis
DE602004028463D1 (en) 2003-05-30 2010-09-16 Pelikan Technologies Inc METHOD AND DEVICE FOR INJECTING LIQUID
EP1633235B1 (en) 2003-06-06 2014-05-21 Sanofi-Aventis Deutschland GmbH Apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US7597793B2 (en) 2003-06-20 2009-10-06 Roche Operations Ltd. System and method for analyte measurement employing maximum dosing time delay
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US7604721B2 (en) 2003-06-20 2009-10-20 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7220034B2 (en) * 2003-07-11 2007-05-22 Rudolph Technologies, Inc. Fiber optic darkfield ring light
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US8450079B2 (en) 2003-10-31 2013-05-28 Immunetics, Inc. Method for detecting bacteria
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
AU2005212396A1 (en) 2004-02-06 2005-08-25 Bayer Healthcare Llc Oxidizable species as an internal reference for biosensors and method of use
EP1751546A2 (en) 2004-05-20 2007-02-14 Albatros Technologies GmbH & Co. KG Printable hydrogel for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc METHOD AND APPARATUS FOR MANUFACTURING A DEVICE FOR SAMPLING LIQUIDS
US7556723B2 (en) 2004-06-18 2009-07-07 Roche Diagnostics Operations, Inc. Electrode design for biosensor
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US20060002817A1 (en) * 2004-06-30 2006-01-05 Sebastian Bohm Flow modulation devices
US8343074B2 (en) 2004-06-30 2013-01-01 Lifescan Scotland Limited Fluid handling devices
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
CN103558284B (en) 2005-07-20 2017-04-12 安晟信医疗科技控股公司 Gated amperometry
EP3483598B1 (en) 2005-09-30 2024-11-06 Ascensia Diabetes Care Holdings AG Gated voltammetry
US20070267513A1 (en) * 2006-05-17 2007-11-22 Taylor William A Low profile fountain or water display
US10254229B2 (en) 2007-04-18 2019-04-09 Ondavia, Inc. Portable water quality instrument
US20080294024A1 (en) * 2007-05-24 2008-11-27 Cosentino Daniel L Glucose meter system and monitor
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CN107024474B (en) 2012-06-22 2020-11-06 霍夫曼-拉罗奇有限公司 Methods and devices for detecting analytes in body fluids
US9395234B2 (en) 2012-12-05 2016-07-19 Cardiocom, Llc Stabilizing base for scale
US11867631B2 (en) 2014-03-05 2024-01-09 Ondavia, Inc. Portable water quality instrument
WO2016014162A1 (en) 2014-07-25 2016-01-28 Becton, Dickinson And Company Analyte test strip assays, and test strips and kits for use in practicing the same
CN105572065B (en) * 2016-01-29 2018-08-21 福建医科大学 Glucose determination reagent box based on platinum bismuth nanometer Mimetic enzyme
CN106323959B (en) * 2016-08-09 2019-01-18 滁州学院 A kind of colorimetric sensor containing benzothiazole bases dyestuff, preparation method and its application in the detection
US11002682B2 (en) 2018-03-12 2021-05-11 Ondavia, Inc. Aldehyde detection and analysis using surface-enhanced Raman spectroscopy
US11994455B2 (en) 2021-04-01 2024-05-28 Ondavia, Inc. Analyte quantitation using Raman spectroscopy

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL268685A (en) * 1960-09-01
ES310641A1 (en) * 1964-03-20 1965-07-01 Boehringer & Soehne Gmbh PROCEDURE FOR OBTAINING A DIAGNOSTIC MEANS FOR THE RECOGNITION OF THE CONSTITUENTS OF PURE BLOOD
US3552928A (en) * 1967-07-19 1971-01-05 Miles Lab Whole blood separation means and test system using same
US3992158A (en) * 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
FR2295419A1 (en) * 1974-12-21 1976-07-16 Kyoto Daiichi Kagaku Kk REFLECTANCE MEASURING DEVICE AND COMPOSITE TEST PAPER STRUCTURE SUBJECT TO SUCH MEASUREMENT
JPS51114985A (en) * 1975-04-01 1976-10-09 Kyoto Daiichi Kagaku:Kk Mothod to analyse urine, etc.
US4042335A (en) * 1975-07-23 1977-08-16 Eastman Kodak Company Integral element for analysis of liquids
CA1095819A (en) * 1977-01-14 1981-02-17 Eastman Kodak Company Element for analysis of liquids
US4119405A (en) * 1978-02-13 1978-10-10 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances
US4255384A (en) * 1978-08-14 1981-03-10 Fuji Photo Film Co., Ltd. Multilayered integral element for the chemical analysis of the blood
US4258001A (en) * 1978-12-27 1981-03-24 Eastman Kodak Company Element, structure and method for the analysis or transport of liquids
JPS55164356A (en) * 1979-06-08 1980-12-22 Fuji Photo Film Co Ltd Multi-layer analysis sheet for liquid sample analysis
US4816224A (en) * 1980-08-05 1989-03-28 Boehringer Mannheim Gmbh Device for separating plasma or serum from whole blood and analyzing the same
GB2090659A (en) * 1981-01-02 1982-07-14 Instrumentation Labor Inc Analytical device
GB2096314A (en) * 1981-03-26 1982-10-13 Lre Relais & Elektronik Gmbh Apparatus for optoelectric evaluation of test paper strips
JPS57208997A (en) * 1981-06-17 1982-12-22 Fuji Photo Film Co Ltd Liquid analyzing material for oxidase enzyme reaction system
DE3133826A1 (en) * 1981-08-27 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim ANALYSIS TEST STRIP AND METHOD FOR THE PRODUCTION THEREOF
US5095026A (en) * 1983-02-04 1992-03-10 University Of Iowa Research Foundation Prodrugs of carbonic anhydrase inhibitors
EP0171148B1 (en) * 1984-06-13 1991-04-17 ARES-SERONO RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP Devices for use in chemical test procedures
GB8420053D0 (en) * 1984-08-07 1984-09-12 Secr Social Service Brit Enhanced luminescent/luminometric assay
DE3433946A1 (en) * 1984-09-15 1986-03-27 Boehringer Mannheim Gmbh, 6800 Mannheim AGENT AND METHOD FOR DETECTING HYDROGEN PEROXIDE
US4682895A (en) * 1985-08-06 1987-07-28 Texas A&M University Fiber optic probe for quantification of colorimetric reactions
US4714874A (en) * 1985-11-12 1987-12-22 Miles Inc. Test strip identification and instrument calibration
DE3781008T2 (en) * 1986-04-19 1993-04-15 Sanwa Kagaku Kenkyusho Co METHOD FOR MEASURING HYDROGEN PEROXIDE OR MEASURING A PEROXID-RELEASING ENZYME OR BIOCHEMICAL SUBSTRATE.
DE3618752A1 (en) * 1986-06-04 1987-12-10 Bayer Ag 4,6-DINITROBENZTHIAZOLONE HYDRAZONE (2)
EP0253371A1 (en) * 1986-07-15 1988-01-20 Omron Tateisi Electronics Co. Chemical level measurement device with easy action cover and single control mode selection capability
US5029583A (en) * 1986-07-22 1991-07-09 Personal Diagnostics, Inc. Optical analyzer
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5059394A (en) * 1986-08-13 1991-10-22 Lifescan, Inc. Analytical device for the automated determination of analytes in fluids
US4790979A (en) * 1986-08-29 1988-12-13 Technimed Corporation Test strip and fixture
JPH07117492B2 (en) * 1987-01-13 1995-12-18 富士写真フイルム株式会社 Method for manufacturing chemical analysis slide
US4774192A (en) * 1987-01-28 1988-09-27 Technimed Corporation A dry reagent delivery system with membrane having porosity gradient
JPH079069Y2 (en) * 1987-11-24 1995-03-06 オムロン株式会社 Reflector for blank value measurement of biochemical measuring instrument
US4994238A (en) * 1988-06-09 1991-02-19 Daffern George M Constant volume chemical analysis test device
US5215890A (en) * 1988-11-03 1993-06-01 Spyros Theodoropulos Chromogenic substrate to peroxidase enzymes
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
US5252293A (en) * 1989-01-17 1993-10-12 Vladimir Drbal Analytical slide with porous filter membrane
JP2790299B2 (en) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 Penzothiazole derivative
GB8911462D0 (en) * 1989-05-18 1989-07-05 Ares Serono Res & Dev Ltd Devices for use in chemical test procedures
US5306623A (en) * 1989-08-28 1994-04-26 Lifescan, Inc. Visual blood glucose concentration test strip
DE4035052C2 (en) * 1989-11-29 1995-06-08 Boehringer Mannheim Gmbh Test vehicle analyzer
DE4015157A1 (en) * 1990-05-11 1991-11-14 Miles Inc ASYMETRIC SANDWICH MEMBRANES FOR DIAGNOSTIC TEST STRIPS
DE4015590A1 (en) * 1990-05-15 1991-11-21 Boehringer Mannheim Gmbh TEST CARRIER FOR THE DETERMINATION OF IONS
US5167145B1 (en) * 1990-09-19 2000-05-23 David M Butler Measurement of blood coagulation time using infrared electromagnetic energy
US5174963A (en) * 1991-01-07 1992-12-29 United Medical Manufacturing Company Blood glucose reflectance meter including a null prompting means and a device for providing a constant brightness light
US5232668A (en) * 1991-02-27 1993-08-03 Boehringer Mannheim Corporation Test strip holding and reading mechanism for a meter
US5246858A (en) * 1991-02-27 1993-09-21 Boehringer Mannheim Corporation Apparatus and method for analyzing a body fluid
CA2088652C (en) * 1992-02-03 2008-07-29 Yeung S. Yu Improved oxidative coupling dye for spectrophotometric quantitative analysis of analytes
GR1002549B (en) * 1992-05-12 1997-01-28 Lifescan Inc. Fluid conducting test strip with Transport Medium
WO1994018559A1 (en) * 1993-02-11 1994-08-18 Radiometer Medical A/S Asymmetric membrane sensor

Similar Documents

Publication Publication Date Title
MXPA97001795A (en) Coloring copuard for anali spectrophotometric determination
EP1167540B1 (en) Dye couple for spectrophotometric determination of analytes
CA2192744C (en) Stable coupling dye for photometric determination of analytes
MXPA96006509A (en) Stainless coloring colorant for anali photometric determination
AU781213B2 (en) 8-(anilino)-1-naphthalenesulfonate analogs and their use in analyte detection assays
US5453360A (en) Oxidative coupling dye for spectrophotometric quantitive analysis of analytes
EP0058334B1 (en) Improved system for the determination of glucose in fluids
RU2050546C1 (en) Method and composition for determining general glucose contents in the whole blood
CA1217999A (en) Ascorbate interference-resistant composition, device and method for the determination of peroxidatively active substances
JPH04237500A (en) Composition and method for assay of ketone body
JPH0532040B2 (en)
JP2516381B2 (en) Method for quantifying hydrogen peroxide and reagent for quantifying the same
HK1043610B (en) Dye couple for spectrophotometric determination of analytes
EP0476455B1 (en) Phenyl-substituted 2-thiazolyl tetrazolium salt indicators